Cro

© GettyImages/alphaspirit

UK deal sees consolidation of two players in the iPSC space

By Jane Byrne

Axol Biosciences, a UK provider of human induced pluripotent stem cells (iPSC) derived cells, media, and characterization services, has merged with Scotland based, Censo Biotechnologies, a cell biology CRO with expertise in iPSC-related technologies.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers